TY - JOUR T1 - Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study JF - Gastroenterology Y1 - 2015 A1 - M P Curry A1 - Forns, X. A1 - Chung, R.T. A1 - N A Terrault A1 - R S Brown Jr. A1 - Fenkel, J.M. A1 - Gordon, F. A1 - J G O'Leary A1 - Kuo, A. A1 - Schiano, T. A1 - G.T. Everson A1 - E R Schiff A1 - Befeler, A. A1 - E J Gane A1 - Saab, S. A1 - J G McHutchison A1 - Subramanian, G.M. A1 - Symonds, W.T. A1 - Denning, J. A1 - McNair, L. A1 - Arterburn, S. A1 - E. S. Svarovskaia A1 - Moonka, D. A1 - N H Afdhal KW - Anemia KW - Arteries KW - Boston KW - California KW - Carcinoma KW - Cities KW - Colorado KW - complications KW - Fatigue KW - Florida KW - Genotype KW - HCV KW - Headache KW - Health KW - hepatitis KW - Hepatitis C KW - hepatitis C virus KW - Infection KW - Israel KW - Liver KW - Liver Transplantation KW - Los Angeles KW - Massachusetts KW - Medicine KW - methods KW - Michigan KW - Missouri KW - New York KW - New Zealand KW - Patients KW - Philadelphia KW - Recurrence KW - Ribavirin KW - Rna KW - San Francisco KW - sofosbuvir KW - Spain KW - Texas KW - Time KW - transplantation KW - treatment KW - Universities VL - 148 SP - 100-107 IS - 1 ER -